Dynamic Technology Lab’s Enanta Pharmaceuticals ENTA Stock Holding History

Dynamic Technology Lab’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,080	Closed	-$329K	–	1203
2022 Q4	$329K	Sell	7,080 -360	-5%	-$16.4K	0.03%	739
2022 Q3	$386K	Buy	+7,440	New	+$435K	0.04%	724
2022 Q1	–	Sell	-6,190	Closed	-$463K	–	1210
2021 Q4	$463K	Buy	+6,190	New	+$486K	0.05%	628
2019 Q2	–	Sell	-3,039	Closed	-$290K	–	1049
2019 Q1	$290K	Buy	+3,039	New	+$273K	0.05%	687
2018 Q4	–	Sell	-5,412	Closed	-$463K	–	1057
2018 Q3	$463K	Buy	+5,412	New	+$542K	0.06%	557
2018 Q1	–	Sell	-7,240	Closed	-$425K	–	1126
2017 Q4	$425K	Buy	+7,240	New	+$363K	0.08%	519
2016 Q2	–	Sell	-7,055	Closed	-$207K	–	940
2016 Q1	$207K	Buy	+7,055	New	+$196K	0.06%	721

Other funds holding ENTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dynamic Technology Lab's ENTA Position: Q1 2023 in Review

Dynamic Technology Lab sold out of Enanta Pharmaceuticals (ENTA) in Q1 2023, closing a stake of 7,080 shares — an estimated $329K sold.

Dynamic Technology Lab first reported a position in ENTA in Q1 2016 and held it in 7 quarters. The position peaked at $463K in Q4 2021. 144 funds tracked by Wall St. Rank hold ENTA as of Q1 2023.

Dynamic Technology Lab reported no remaining Enanta Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Dynamic Technology Lab sold 7,080 Enanta Pharmaceuticals shares in Q1 2023, an estimated $329K.
Dynamic Technology Lab first reported a position in Enanta Pharmaceuticals in Q1 2016 and held it in 7 quarters.
Dynamic Technology Lab's Enanta Pharmaceuticals position peaked at $463K in Q4 2021.
144 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2023.

Based on Dynamic Technology Lab's 13F filing for Q1 2023, filed 12 May 2023.